Medicine
TECENTRIQ 840 mg
Key ingredient(s)
0 Mg
Atezolizumab 840
Available forms & strengths
Request this medicine| Form | Strength | Pack | Route | Icon |
|---|---|---|---|---|
| INFUSION (PARENTERAL) | 840,0 mg per 14,0 ml | — | Parenteral |
|
Notes: SAHPRA secureId: CfDJ8L67LitnFgdOq0Uv0zyh2bq8JSzg4e0h9QNN5sGJcafsAC80cPta0KIlZKMkfoTHISgXbx6dojQRiJlbzC7KznEkA06PRh0bnyzA6g_IzFCx32pz8Fon5oXgXechSZrY2w | Reg: 54/30.1/0060 | AppNo: 540060 | RegDate: 2020/09/29 | Applicant: Roche Products (Pty) Ltd | Status: Registered